Filing Details

Accession Number:
0001387131-19-009327
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-04 07:00:27
Reporting Period:
2019-12-03
Accepted Time:
2019-12-04 07:00:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1430306 Tonix Pharmaceuticals Holding Corp. TNXP Pharmaceutical Preparations (2834) 261434750
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1563420 Seth Lederman C/O Tonix Pharmaceuticals Holding Corp
509 Madison Avenue, Suite 1608
New York NY 10022
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2019-12-03 20,000 $1.16 23,267 No 4 P Indirect By 401(k) plan
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By 401(k) plan
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value 459 Indirect By IRA Account
Common Stock, $0.001 Par Value 177 Direct
Common Stock, $0.001 Par Value 31 Indirect By spouse
Common Stock, $0.001 Par Value 30 Indirect By Leder Laboratories, Inc.
Common Stock, $0.001 Par Value 30 Indirect By Starling Pharmaceuticals, Inc.
Common Stock, $0.001 Par Value 205 Indirect By Lederman & Co., LLC
Common Stock, $0.001 Par Value 33 Indirect By L&L Technologies, LLC
Common Stock, $0.001 Par Value 59 Indirect By Targent Pharmaceuticals, LLC
Footnotes
  1. The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp., any security holder of Tonix Pharmaceuticals Holding Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.